Amgen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

09.01.18	Belgium's Biocartis, Amgen In Deal To Develop Idylla CDx Biomarker Tests (RTTNews)
08.01.18	Amgen Says EMA Accepts Filing For EVENITY Application (RTTNews)
08.01.18	European Medicines Agency Accepts Filing For EVENITY™ (Romosozumab) (PR Newswire)
05.01.18	Amgen Says FDA Approves SBLA For XGEVA (RTTNews)
05.01.18	FDA Approves XGEVA® (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma (PR Newswire)
16.12.17	Centene's Washington Subsidiary Reaches agreement with State of Washington (PR Newswire)
14.12.17	Amgen Teams Up With Cambridge Biotech Community To Select Two Startups To Receive Golden Tickets At LabCentral (PR Newswire)
14.12.17	Mapp Enables DMLS To On-Board Over 20 Brands And Deliver Over 700 Million Emails In 18 Months (PR Newswire)
12.12.17	Amgen Announces 15 Percent Increase In 2018 First Quarter Dividend (PR Newswire)
11.12.17	KYPROLIS® (carfilzomib) Extended Overall Survival In Patients With Relapsed Or Refractory Multiple Myeloma In Phase 3 ASPIRE Trial (PR Newswire)
11.12.17	Amgen Foundation Pledges Up To $500,000 In Relief To Victims Of The Southern California Wildfires (PR Newswire)
10.12.17	Repatha & Praluent: A Tale Of Two Rivals... (RTTNews)
07.12.17	New Data To Be Presented At ASH 2017 Underscore Amgen's Commitment To Improving Lives And Changing Outcomes For Patients With Difficult-To-Treat Blood Cancers (PR Newswire)
06.12.17	Amgen To Webcast Investor Call At ASH 2017 (PR Newswire)
04.12.17	Biocartis Signs Diagnostic Development Agreement With Amgen For Idylla RAS Tests (RTTNews)
01.12.17	FDA Approves Amgen's Repatha® (evolocumab) To Prevent Heart Attack And Stroke (PR Newswire)
29.11.17	Aimovig™ (erenumab) Phase 3 STRIVE Data Published In The New England Journal Of Medicine Demonstrate Significant, Sustained Efficacy In Migraine Prevention (PR Newswire)
29.11.17	Biotech Stocks Facing FDA Decision In December (RTTNews)
27.11.17	Amgen To Present At The Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference (PR Newswire)
17.11.17	Amgen Launches The ENBREL Mini™ Single-Dose Prefilled Cartridge With AutoTouch™ Reusable Autoinjector That Is Ergonomically Designed For Patients (PR Newswire)
13.11.17	New Analyses Presented At AHA 2017 Show Repatha® (evolocumab) Significantly Reduced Cardiovascular Events In Patients With Peripheral Artery Disease And In Patients With A History Of Heart Attacks (PR Newswire)
10.11.17	Amgen Gets Positive CHMP Opinion To Expand Use Of Nplate In Pediatric Patients (RTTNews)
10.11.17	Amgen, Allergan Get Positive CHMP Opinion For ABP 215, Biosimilar Bevacizumab (RTTNews)
10.11.17	Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate® (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura (PR Newswire)
10.11.17	Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer (PR Newswire)
06.11.17	Amgen Announces New Analyses Of High-Risk Patient Subgroups From Repatha® (evolocumab) Cardiovascular Outcomes Study At AHA Scientific Sessions 2017 (PR Newswire)
03.11.17	Novartis, Amgen Report Expanded Collaboration With Banner Alzheimer's Institute (RTTNews)
02.11.17	Amgen And Novartis Announce Expanded Collaboration With Banner Alzheimer's Institute In Pioneering Prevention Program (PR Newswire)
31.10.17	Amgen Inc. -- Moody's assigns Baa1 to Amgen's notes; stable outlook (Moodys)
31.10.17	Kirin-Amgen JV To Become Wholly-owned Subsidiary Of Amgen - Quick Facts (RTTNews)
31.10.17	Kirin-Amgen Joint Venture To Become Wholly-Owned Subsidiary Of Amgen (PR Newswire)
26.10.17	Amgen-Aktie verliert nachbörslich trotz Erhöhung der Gewinnprognose (AWP) Der weltweit grösste Biotech-Konzern Amgen hat seine Gewinnziele nach oben geschraubt.» mehr
25.10.17	Amgen Increases 2017 Non-GAAP EPS Guidance - Quick Facts (RTTNews)
25.10.17	EARNINGS SUMMARY: Details of Amgen Inc. Q3 Earnings Report (RTTNews)
25.10.17	Amgen Reports Third Quarter 2017 Financial Results (PR Newswire)
24.10.17	Amgen Announces Appointment Of Wanda M. Austin To Board Of Directors (PR Newswire)
24.10.17	Amgen Announces 2017 Fourth Quarter Dividend (PR Newswire)
23.10.17	Phase 3 A.R.R.O.W. Study Of Once-Weekly KYPROLIS® (Carfilzomib) Regimen Meets Primary Endpoint Of Progression-Free Survival In Relapsed And Refractory Multiple Myeloma Patients (PR Newswire)
20.10.17	Amgen Announces Webcast of 2017 Third Quarter Financial Results (PR Newswire)
16.10.17	Amgen And Boston Children's Hospital Enter A Collaboration To Find New Genes And Drug Targets For Severe Pain Syndromes (PR Newswire)
16.10.17	UBS Keyinvest Daily Markets: Amgen - Rücklauf an alte Höchststände (finanzen.ch)
12.10.17	Amgen Foundation Awards Khan Academy $3 Million To Support Development Of Free Comprehensive Biology Lessons (PR Newswire)
10.10.17	Amgen : FDA Accepts SBLA For Prolia (RTTNews)
09.10.17	FDA Accepts Supplemental Biologics License Application For Prolia® (Denosumab) In Glucocorticoid-Induced Osteoporosis (PR Newswire)
09.10.17	New Drugs Approved In September (RTTNews)
06.10.17	Amgen And LabCentral Open Nomination Process For Lab Residency (PR Newswire)
05.10.17	First Randomized Study To Evaluate IMLYGIC® (Talimogene Laherparepvec), An Oncolytic Viral Therapy, In Combination With A Checkpoint Inhibitor Published In The Journal Of Clinical Oncology (PR Newswire)
03.10.17	Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

17:58		Handel in Frankfurt: SDAX liegt letztendlich im Plus
17:58		Schwache Performance in Europa: Euro STOXX 50 gibt letztendlich nach
15:58		Schwache Performance in Frankfurt: TecDAX zeigt sich nachmittags schwächer
15:58		Handel in Europa: So bewegt sich der Euro STOXX 50 aktuell
15:58		XETRA-Handel: SDAX am Nachmittag freundlich
13:28		Bayer-Analyse: DZ BANK verleiht Bayer-Aktie Kaufen in jüngster Analyse
12:26		Schwacher Wochentag in Europa: So performt der Euro STOXX 50 mittags
12:26		Mittwochshandel in Frankfurt: TecDAX gibt am Mittag nach

17:58

Handel in Frankfurt: SDAX liegt letztendlich im Plus

17:58

Schwache Performance in Europa: Euro STOXX 50 gibt letztendlich nach

15:58

Schwache Performance in Frankfurt: TecDAX zeigt sich nachmittags schwächer

15:58

Handel in Europa: So bewegt sich der Euro STOXX 50 aktuell

15:58

XETRA-Handel: SDAX am Nachmittag freundlich

13:28

Bayer-Analyse: DZ BANK verleiht Bayer-Aktie Kaufen in jüngster Analyse